|
Market Cap (17-May) $18,062,432 (1,390th) |
Close (30-Jun) $0.040 |
Volume (30-Jun) 0 |
Shortsold (21-Feb) 50,867 (0.01%) (619th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.06 |
AC8 released this announcement to the ASX on 8 February 2022, 10:59. The announcement is marked as price sensitive, and is 2 page(s) in length and 143.56kb in size.
You can view all announcements from AC8 and see how they appear on a price chart on the announcements page.
At the date of this announcement, AC8 was 0.013% short sold according to ASIC data. It was ranked the 602nd most shorted stock on the ASX. It remains ranked 619th as of the latest reported data (21 February 2022).
| Other Recent Announcements from AC8 | |
|---|---|
| Final Director's Interest Notice - C. Mews | 29 June 2023, 9:44 |
| Initial Director's Interest Notice - B. Mitchell | 29 June 2023, 9:44 |
| Appointment of Independent Non-Executive Director | 29 June 2023, 9:19 |
| AusCann Receives Positive MOC from the U.S. FDA for CPAT-01 | 8 February 2022, 10:59 |
| December 2021 Quarterly Activities and Cashflow Reports | 28 January 2022, 8:56 |
| AusCann Advances DermaCann Registration & US Launch | 15 December 2021, 9:42 |
| Initial Director's Interest Notice - T. McGrouther | 15 December 2021, 9:35 |
You must be logged in to post a reply.
AusCann Group Holdings Ltd 